Daily non-political popular news in brief.

1-visit screening, prevention for cervical cancer holds promise

A method of screening women in Ghana for early signs of cervical cancer and providing preventive treatment at the same visit appears to be safe, acceptable to women and feasible, according to a study by a researcher at the Stanford University School of Medicine.

Read more »

Keywords: 1-visit, screening, prevention, cervical, cancer, holds, promise, visit, hold

« Previous | Next »

Similar news on "1-visit screening, prevention for cervical cancer holds promise":

1. 'Swish-and-spit' test accurate for cancer
   01-01-2008 · EurekAlert!
   A morning gargle could someday be more than a breath freshener -- it could spot head and neck cancer, say scientists at the Johns Hopkins Kimmel Cancer Center. Their new study of a mouth rinse that captures genetic signatures common to the disease holds promise for screening those at high risk, including heavy smokers and alcohol drinkers.
   Similar news · Read more »
   
2. Enzyme eliminated by cancer cells holds promise for cancer treatment
   07-18-2007 · EurekAlert!
   An enzyme that cancer cells eliminate, apparently so they can keep proliferating, may hold clues to more targeted, effective cancer treatment, scientists say.
   Similar news · Read more »
   
3. High HPV concentrations combined with smoking significantly raise risks of cervical cancer
   11-17-2006 · EurekAlert!
   Cigarette smoking and concurrent infection with high levels of the virus associated with cervical cancer can increase cancer risk by as much as 27 times, according to a study published in the November 2006 issue of Cancer Epidemiology, Biomarkers & Prevention.
   Similar news · Read more »
   
4. Study: HPV test beats Pap in detecting cervical cancer
   10-17-2007 · EurekAlert!
   A new study led by McGill University researchers shows that the human papillomavirus screening test is far more accurate than the traditional Pap test in detecting cervical cancer. The first round of the Canadian Cervical Cancer Screening Trial concluded that the HPV test's ability to accurately detect pre-cancerous lesions without generating false negatives was 94.6 percent, as opposed to 55.4 percent for the Pap test.
   Similar news · Read more »
   
5. Brain cleaner
   01-17-2007 · EurekAlert!
   Brain injury causes glutamate, a substance necessary for proper brain function, to flood areas surrounding the trauma and kill other cells. Weizmann Institute scientists have developed a new way to rid the brain of excess glutamate. This method -- which uses an enzyme found in blood -- could lead to new therapies not only for brain injury, but also for stroke and other conditions, and holds promise for prevention of damage from meningitis or nerve gas.
   Similar news · Read more »
   
6. New cervical cancer test increases the detection rate of abnormal cells
   07-02-2007 · EurekAlert!
   A new computerised screening test for cervical cancer detects more abnormalities than the traditional smear test, according to a study published online.
   Similar news · Read more »
   
7. Discovery of widespread tumor growth gene holds promise for effective anti-cancer treatment
   09-23-2007 · EurekAlert!
   Italian scientists will announce on Monday (Sept. 24) that they have found a new and promising target for anti-tumor therapy in cancer. Professor Saverio Alberti, from the CESI, University of Chieti Foundation, Chieti, will tell the European Cancer Conference that he and his team have found a widespread mechanism for the stimulation of tumor growth in man, and that this is leading to the development of novel diagnostic and therapeutic procedures.
   Similar news · Read more »
   
8. Green tea holds promise as new treatment for inflammatory skin diseases
   08-06-2007 · EurekAlert!
   Green tea could hold promise as a new treatment for skin disorders such as psoriasis and dandruff, Medical College of Georgia researchers say.
   Similar news · Read more »
   
9. Safety of new microbicide for HIV prevention to be tested in young women in US trial
   07-09-2007 · EurekAlert!
   In an effort to help stem the tide of the HIV/AIDS epidemic, particularly in women, researchers have launched a clinical safety trial of a topical vaginal microbicide with a unique molecular structure that holds promise for preventing the sexual transmission of HIV. The Microbicide Trials Network is leading the NIH-funded study in which VivaGel is being tested for the first time in sexually active young women to determine its safety, acceptability and ease of use.
   Similar news · Read more »
   
10. Study shows continued success for new HPV vaccine against virus responsible for cervical cancer
    05-09-2007 · EurekAlert!
    A new vaccine aimed at preventing cervical cancer is nearly 100 percent effective against the two types of the human papillomavirus responsible for most cases of cervical cancer. Researchers at more than a dozen international medical centers evaluated the efficacy of quadrivalent vaccine targeting HPV types 6, 11, 16 and 18 in more than 12,000 women ages 15 to 26 in 13 countries for nearly three years. They found a near 100 percent efficacy rate in prevention of HPV types 16 and 18.
    Similar news · Read more »